Indicator for Prediction of Iron Deposition Control and Long-term Response to Deferasirox: A Pharmacokinetic Study
碩士 === 臺北醫學大學 === 藥學系(碩博士班) === 102 === β-thalassemia major is an autosomal recessive hereditary anemia. Lifelong regular transfusions are necessary in these patients, and appropriate iron chelation therapy is needed to prevent iron overload resulting from frequent blood transfusions. Deferasirox (D...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/64twn5 |